+ T cells are maintained in secondary lymphoid tissues, peripheral tissues, and BM by homeostatic proliferation. Their survival has been shown to be dependent on IL-7, but it is unclear where they acquire it. Here we show that in murine BM, memory CD8 
Introduction

Memory CD4
+ and memory plasma cells residing in the BM are maintained in survival niches organized by dedicated reticular stromal cells expressing IL-7 and CXCL12, respectively [1] [2] [3] [4] [5] . They rest in terms of proliferation and activation, with the exception that memory plasma cells secrete large quantities of antibodies. The survival of BM memory cells is conditional on signals from these niches. While the numbers of memory CD4 + T cells in the periphery dwindle, memory CD4 + T cells of the BM survive for long periods of time, months in mice [4] and decades in humans [6] . BM also hosts a prominent population of memory CD8 + T cells [7] [8] [9] [10] [11] . In humans, 60% of these cells express CD69, reminiscent of recently activated T cells [9] . It has been claimed that memory CD8 + T cells undergo extensive homeostatic proliferation in BM and spleen [8, 12] . This led to the conclusion that the population of memory CD8 + T cells in the BM is maintained as activated cells, by cytokine-driven "homeostatic" proliferation, with dividing memory cells constantly replacing dying memory cells [13] .
Maintenance of memory CD8 + T cells is also dependent on IL-7 [14, 15] , but so far it has not been clear, when and where the T cells acquire this IL-7. Here we show that more than 90% of the memory CD8 
Results
BM is a major compartment for memory CD8 + T-cell maintenance
Murine BM contains a prominent population of CD44 + CD8 + T cells, as large as the population of CD44 + CD8 + T cells in the spleen (Fig. 1A) . In order to determine where memory CD8 + T cells are maintained in the long run after a systemic immune response, we tracked Ag-specific CD8 + T cells into the memory phase of a secondary immune response. WT C57BL/6 mice were immunized with cationized OVA and LPS i.p. and challenged 4 weeks later the same way. CD8 + T cells recognizing the OVApeptide SIINFEKL were detected by H2K b /SIINFEKL-pentamers.
On day 7 of the immune response, the spleen contained 6.2 × 10 4
Ag-specific CD8 + T cells and the BM 1.1 × 10 4 (Fig. 1B) . On day 34, the number of Ag-specific CD8 + T cells dropped to 1 × 10 4 in spleen and 6.6 × 10 3 in BM. In BM, the numbers of specific CD8 + T cells remained relatively constant thereafter, whereas in spleen the numbers continued to decline slowly to 9 × 10 2 on day 188. In a second experiment, numbers of specific CD8 + T cells in spleen and BM remained constant as well, at about 3 × 10 3 , on day 181
(Supporting Information Fig. 1A ). In two other independent experiments, the Ag-specific cells were detected in the BM after a year, demonstrating long-term survival of memory CD8 + T cells in the BM, presumably for the lifetime of a mouse (Supporting Information Fig. 1B) . A similar distribution was observed for GP [33] [34] [35] [36] [37] [38] [39] [40] [41] ( Fig. 1D and E). Twenty to thirty percent of the IFN-γ-producing CD8 + T cells also expressed IL-2 ( Fig. 1D and E) . When restimulated in vitro, IFN-γ + CD8 + memory T cells from spleen and BM also expressed CD107a, a marker of degranulation (Fig. 1F) . Thus, memory CD8 + T cells generated by defined systemic murine immune responses are maintained in BM as well as in spleen, and they display cytotoxic functions when stimulated with their cognate Ag.
Memory CD8 + T cells are residing on IL-7-producing stromal niches in BM
Memory CD4
+ T cells and memory plasma cells are maintained in distinct stromal niches in BM [5, 16] . Memory plasma cells survive in a niche composed of CXCL12-producing stromal cells and eosinophils [1, 17, 18] , while memory CD4 + T cells contact IL-7-producing stromal cells [4] . IL-7 is a mandatory survival factor for both memory CD8 + and CD4 + T cells [14, 19] www.eji-journal.eu Fig. 2A) and about 50 % of the reticular stromal cells express GFP (Fig. 2B) + CD8 + CD44 + cell interactions with GFP + (IL7 + ) cells were quantified manually by counting. The frequencies of CD3 + CD8 + CD44 + cells that are contacting directly are shown, which are located within or further than 10 μm distance to the GFP + stromal cells. Data are shown as mean ± SEM (50-180 CD3 + CD8 + CD44 + cells were counted from each mouse) and are pooled results from one naive, two OT-I transferred, and one nontransferred mice immunized with OVA + LPS. (E) Mice expressing GFP ubiquitously were irradiated and T cell depleted BM cells were transferred one day later. Four weeks after reconstitution, BM of these mice were analyzed for CD8
cells (
+ and CD4 + T-cell interactions with GFP + nonhematopoietic cells. BM sections were stained for CD4 + (green), CD8α (blue), CD3 (red), and CD44 (turquoise Fig. 4C and D) . Ki-67 expression correlated with BrdU incorporation indicating that the increase in Ki-67 expression was due to the active proliferation of the cells (Fig. 4C) . Furthermore, the frequencies of cells in S and G 2 /M phases increased significantly, as shown by PI staining, that is, from 0.4 to 5.4% in CD8 + memory T cells from BM (Fig. 4E) .
Thus, BrdU is activating resting memory CD8 + T cells both in spleen and BM to leave the G 0 phase of cell cycle and start to synthesize DNA.
Memory CD8 + T cells of BM rest in terms of gene expression
Tracking of Ag-specific CD8 + T cells into the memory phase of an immune response revealed that those cells express CD127, the IL-7 receptor α chain, in the memory phase (Supporting Information  Fig. 4) . To compare the transcriptomes of resting memory CD8 + T cells from spleen and BM, we isolated CD44 + CD127 + CD8 + T cells from spleen and BM (Supporting Information Fig. 5 ), using an approach that we had demonstrated before to conserve the in vivo gene expression [37] . activated with anti-CD3/anti-CD28 for 42-44 h, the amount of RNA increased to an average of 15 pg/cell in spleen and 20 pg/cell in BM memory CD8 + T cells, indicating that before activation, the cells had been resting in terms of transcription (Fig. 5A) . A global overview on genes transcribed in memory T cells from BM and spleen, as obtained by analysis with Affymetrix MG U430 2 GeneChips, shows that 11 806 genes were expressed differentially (fold change >2/pg RNA) between naive and memory CD8 + T cells from BM and spleen isolated ex vivo, on the one hand, and those cells reactivated with anti-CD3 and anti-CD28 (Fig. 5B) .
We next compared the expression of individual genes expressed by resting versus activated CD8 + memory. Genes reflecting recent activation events, like the genes encoding 4-1BB (Tnfrsf9), CD25
(Il2ra), cytotoxic T lymphocyte associated protein 4 (Ctla4), were barely transcribed in naive and ex vivo isolated memory CD8 + T cells from BM and spleen, whereas they were upregulated 10-to 130-fold per picogram RNA, following in vitro activation (Fig. 5C) . Genes encoding cytokines and cytolytic effector molecules, such as IFN-γ (Ifng), lymphotoxin α (Lta), perforin (Prf), and granzyme B (Gzmb) were expressed at signal strengths of 600 and below, per picogram RNA, while they were expressed at signal strengths of 2000-10 000 per picogram RNA in activated cells (Fig. 5D ). The same result was observed for genes involved in cell cycle progression, namely, the genes encoding the proteins cyclin E1, E2, A2, and B1, which are expressed in S, G 2 , and M phases of cell cycle, respectively [38, 39] . These genes were expressed at signal strengths of about 1000 in activated cells and less than 100 in resting memory T cells from BM or spleen, per picogram RNA (Fig. 5E) . Likewise, expression of Mki67, the gene encoding the protein Ki-67, was induced upon activation of the T cells about 20-to 40-fold per picogram RNA. Thus, in terms of RNA and gene expression, CD8
+ memory T cells from spleen and BM are similar and resting.
Discussion
Here we show that CD8 + memory T lymphocytes generated in systemic immune reactions are maintained in the spleen and BM of mice, for long periods of time, most likely extending to the lifetime of the mice. Such cells are resting in terms of proliferation and gene expression, and the ones in BM reside in niches organized by IL-7-expressing mesenchymal stromal cells. Analysis of phenotypic markers revealed that memory CD8 + T cells of BM resemble tissue-resident memory cells, since 30% of them express CD69 and lack expression of S1PR1, KLRG1, and CD62L [24, 27, 32, 33] . It has been previously shown that the BM is a preferred residency of memory plasma cells [2, 40] and CD4 + memory T cells [16] that are generated in systemic immune responses, and are maintained in the apparent absence of Ag [41, 42] . Plasmablasts generated in secondary immune reactions migrate from secondary lymphoid organs into BM within a week [43] [44] [45] and dock on to reticular stromal cells expressing the chemokine CXCL12 [1] . About 10-20% of the plasmablasts generated in the immune reaction develop into memory plasma cells and survive in their niches presumably for a lifetime [3] . CD4 + memory T-cell precursors translocate from secondary lymphoid organs into the BM in the contraction phase of an immune reaction. Likewise, 10-20% of the cells generated in that immune reaction develop into memory CD4 + T cells in the BM, in niches organized by IL-7-expressing reticular stromal cells [4] . Here we confirm that the BM is also a major compartment for the maintenance of memory CD8 + T cells, reporter mice [46] . IL-7 has been shown to be essential for the survival of CD8 + T cells [14, 15] . IL-7-producing stromal or epithelial cells have been found in the thymus, peripheral LNs, spleen, gut, and BM, but their relevance for the maintenance of CD8 memory is not clear [20, [46] [47] [48] [49] . The colocalization of resting memory CD8 + T cells and IL-7-expressing stromal cells in the BM strongly suggests that the BM is a privileged site for the maintenance of CD8 + T-cell memory. As memory CD4 + T cells are also located close to IL-7-producing stromal cells [4] , it remains to be shown whether memory CD4 + and CD8 + T cells compete for the same survival niches or whether they occupy distinct niches specialized for memory CD4 + and CD8 + T-cell maintenance. (gene encoding for 4-1BB), Il2ra, nor do they express cytokine genes, although they can readily be induced to do so by cognate reactivation.
As we show here, about 30% of murine CD8 + memory T cells in BM are CD69 + and their numbers remain constant for months after priming. In humans, about 60% of the BM CD8 + memory T cells express CD69 [6] , which has been interpreted as a hallmark of "activation" [9] . It has been reported before that also resting CD4 + human memory T cells from BM express CD69 [6, 9] , and that this is required for murine CD4 + memory T cell entry into the BM [21] . CD69 also has been identified as a retention marker, in conjunction with S1PR1, which allows cells to enter blood [30] . Taken together, CD69 expression by memory T cells of BM is most likely not an indicator of activation but suggests that these cells are resident within BM as demonstrated previously for other organs [24, 27, 32, 33] . CD8 + memory T cells of the BM are also resting in terms of proliferation. Here we used Ki-67 to discriminate between cells in the G 0 phase of cell cycle, which do not express Ki-67, and cells in the G 1 to M phase of cell cycle, which do express Ki-67 [36] . About 95% of the CD8 + memory T cells of BM, and 90% in the spleen, were in G 0 ,that is, they were not proliferating. This is similar to the situation in human BM, where more than 95% of the CD4 + and CD8 + memory T cells were Ki-67 − [6] . Of the few cells that were not in G 0 , about 0.5-5% were in the S/G 2 /M phase of cell cycle, that is, were actively proliferating at the time of analysis. This corresponds to less than 0.05-0.5% of all CD8 + memory T cells. This finding contrasts sharply with previous analyses, in which the frequencies of proliferating CD8 + memory T cells in the BM were calculated according to BrdU incorporation into cellular DNA, in cells undergoing active DNA synthesis [8, 12, 13] . These studies had suggested that over a time period of 40 days about 80% of the memory CD8 + T cells proliferate in the BM [13] . 
Materials and methods
Mice
C57BL/6J mice (B6) and OT-I mice were purchased from Charles River (Sulzfeld, Germany) and Jackson Laboratories, respectively. IL-7 knock-in mice were kindly provided by Koichi Ikuta. Mice expressing GFP ubiquitously (Ubq:GFP) were bred in DRFZ. All mice were housed under specific pathogen-free conditions. All animal experiments were performed according to institutional guidelines and Japanese and German Federal laws on animal protection.
Immunization, LCMV infection, and adoptive T-cell transfer
Mice aged 8-12 weeks were immunized twice at 4 week intervals with 100 μg cationized OVA and 10 μg LPS (Salmonella minnesota, Invivogen 
BrdU staining and cell cycle analysis
Ex-breeder mice were fed with 1 mg/mL BrdU in drinking water containing 0.1 g/mL sugar for 3 days. As controls, some mice were fed with water containing sugar only. A total of 5 × 10 6 spleen and BM cells were stained for cell surface markers and were fixed and permeabilized according to a modified BrdU staining protocol provided with BrdU Flow Kit (BD Pharmingen, BD Cytoperm Permeabilization Buffer Plus was replaced with 0.01% Triton X-100 [Sigma-Aldrich]/1%BSA/PBS). Cells were then stained with anti-Ki-67 and anti BrdU (3D4, BD Pharmingen) for 30 min at room temperature. For cell cycle analysis, 2-3 × 10 6 cells were stained with cell surface molecules and Ki-67 as explained above. Cells were then treated with 200 μg/mL RNase A (Qiagen) and 20 μg/mL propidium iodide (Invitrogen) in PBS for 30 min at room temperature and directly measured at a MACSQuant flow cytometer.
Preparation of BM histological sections and confocal microscopy
Femurs were fixed in 4% PFA (Electron Microscopy Sciences) for 4 h at 4°C, equilibrated in 30% sucrose/PBS. Bones were frozen and cryosectioned using Kawamoto's film method [55] . Six micrometer sections were stained with Abs in 0.1% Tween-20 (Sigma-Aldrich)/5% FCS/PBS after blocking with 5% FCS/PBS for 30 min. The following primary and secondary reagents were used: anti-CD8α (53-6.7, DRFZ), anti-CD3 (eBio500A2, eBioscience), anti-CD4 (GK1.5, DRFZ), anti-CD44 (IM7, DRFZ), anti-GFP (polyclonal rabbit, Life Technologies), digoxygenin-coupled anti-mouse/human fibronectin (polyclonal rabbit, Sigma-Aldrich, coupled in DRFZ), anti-rat-Alexa 555/Alexa 647 (polyclonal goat, Life Technologies), anti-rabbit A488 (polyclonal donkey, Life Technologies), anti-digoxygenin-Alexa 594 (DRFZ), streptavidinAlexa 594 (Life Technologies). For the nuclear staining, sections were stained with 1 μg/mL DAPI in PBS. Sections were mounted with Fluorescent Mounting Medium (DAKO). All confocal microscopy was carried out using a Zeiss LSM710 with a 20×/0.8 numerical aperture objective lens and all images were generated by maximum intensity projection of 3-5 Z-stacks each with 1 μm thickness. Image acquisition was performed using Zen 2010 Version 6.0 and images were analyzed by Zen 2009 Light Edition software (Carl Zeiss MicroImaging).
Generation of chimeric mice
BM chimeras were generated from mice that are expressing GFP ubiquitously. The mice were irradiated twice (within 3 h) with 3.75 Gy and reconstituted 24 h later with 3 × 10 6 total BM cells from C57BL/6J mice, which had been depleted of CD90 + cells by MACS CD90.2 MicroBeads (Miltenyi Biotec) before transfer. Mice were treated with 1 mg/mL Neomycin (Sigma-Aldrich) and vitamins (Ursovit, Serumwerke Bernburg) for 16 days, starting 2 days before irradiation. Four weeks after reconstitution, mice were sacrificed and femurs were frozen. Chimerism was confirmed by flow cytometry.
